Biotech Stock MoonLake Rises After Arthritis Drug Tops AbbVie's Humira investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.
Polar Capital Holdings Plc lessened its holdings in MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) by 41.9% during the third quarter, HoldingsChannel.com reports. The firm owned 939,012 shares of the company’s stock after selling 676,377 shares during the period. Polar Capital Holdings Plc’s holdings in MoonLake Immunotherapeutics were worth $53,524,000 as of its most recent SEC […]
MoonLake announces significant improvements with Nanobody® sonelokimab over 24 weeks in active psoriatic arthritis (PsA) and other important updates at its R&D Day marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
MoonLake Immunotherapeutics AG: MoonLake announces significant improvements with Nanobody® sonelokimab over 24 weeks in active psoriatic arthritis (PsA) and other important updates at its R&D Day finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
MoonLake announces significant improvements with Nanobody® sonelokimab over 24 weeks in active psoriatic arthritis (PsA) and other important updates at.